Ipca Laboratories Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Pranay Godha
Chief executive officer
₹65.2m
Total compensation
| CEO salary percentage | 25.7% |
| CEO tenure | 1.7yrs |
| CEO ownership | 0.7% |
| Management average tenure | no data |
| Board average tenure | 9.5yrs |
Recent management updates
Recent updates
Why We're Not Concerned About Ipca Laboratories Limited's (NSE:IPCALAB) Share Price
Dec 20
Ipca Laboratories (NSE:IPCALAB) Is Paying Out A Dividend Of ₹2.00
Nov 17Earnings Tell The Story For Ipca Laboratories Limited (NSE:IPCALAB)
Sep 10Ipca Laboratories' (NSE:IPCALAB) Solid Earnings Have Been Accounted For Conservatively
Jun 07Ipca Laboratories Limited (NSE:IPCALAB) Not Lagging Market On Growth Or Pricing
May 24Investors Interested In Ipca Laboratories Limited's (NSE:IPCALAB) Earnings
Feb 07Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Jan 09Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Aug 20Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet
Feb 28Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Sep 20Estimating The Intrinsic Value Of Ipca Laboratories Limited (NSE:IPCALAB)
Aug 31Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Jun 22Calculating The Fair Value Of Ipca Laboratories Limited (NSE:IPCALAB)
May 28Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Mar 15These 4 Measures Indicate That Ipca Laboratories (NSE:IPCALAB) Is Using Debt Reasonably Well
Sep 20Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?
Aug 09Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Jun 08How Does Ipca Laboratories Limited (NSE:IPCALAB) Stand Up To These Simple Dividend Safety Checks?
Mar 26Do Ipca Laboratories's (NSE:IPCALAB) Earnings Warrant Your Attention?
Mar 13Trade Alert: The Compliance Officer Of Ipca Laboratories Limited (NSE:IPCALAB), Harish Kamath, Has Sold Some Shares Recently
Feb 28Ipca Laboratories Limited's (NSE:IPCALAB) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 23Does Ipca Laboratories' (NSE:IPCALAB) CEO Salary Compare Well With Industry Peers?
Feb 11Could The Ipca Laboratories Limited (NSE:IPCALAB) Ownership Structure Tell Us Something Useful?
Jan 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹7b |
| Jun 30 2024 | n/a | n/a | ₹6b |
| Mar 31 2024 | ₹65m | ₹17m | ₹5b |
| Dec 31 2023 | n/a | n/a | ₹6b |
| Sep 30 2023 | n/a | n/a | ₹5b |
| Jun 30 2023 | n/a | n/a | ₹5b |
| Mar 31 2023 | ₹51m | ₹13m | ₹5b |
| Dec 31 2022 | n/a | n/a | ₹5b |
| Sep 30 2022 | n/a | n/a | ₹6b |
| Jun 30 2022 | n/a | n/a | ₹7b |
| Mar 31 2022 | ₹46m | ₹12m | ₹9b |
| Dec 31 2021 | n/a | n/a | ₹9b |
| Sep 30 2021 | n/a | n/a | ₹10b |
| Jun 30 2021 | n/a | n/a | ₹10b |
| Mar 31 2021 | ₹32m | ₹8m | ₹11b |
| Dec 31 2020 | n/a | n/a | ₹11b |
| Sep 30 2020 | n/a | n/a | ₹10b |
| Jun 30 2020 | n/a | n/a | ₹9b |
| Mar 31 2020 | ₹33m | ₹8m | ₹6b |
| Dec 31 2019 | n/a | n/a | ₹6b |
| Sep 30 2019 | n/a | n/a | ₹6b |
| Jun 30 2019 | n/a | n/a | ₹5b |
| Mar 31 2019 | ₹29m | ₹8m | ₹4b |
| Mar 31 2018 | ₹25m | ₹7m | ₹2b |
Compensation vs Market: Pranay's total compensation ($USD765.06K) is about average for companies of similar size in the Indian market ($USD605.16K).
Compensation vs Earnings: Pranay's compensation has increased by more than 20% in the past year.
CEO
Pranay Godha (52 yo)
1.7yrs
Tenure
₹65,228,222
Compensation
Mr. Pranay Premchand Godha served as the President of APIs & Generics at Ipca Laboratories Limited and joined it on April 16, 2003. He serves as Non-Executive, Non-Independent Director at Unichem Laborator...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 49.2yrs | ₹123.00m | 2.29% ₹ 9.2b | |
| CEO, MD & Executive Director | 16.1yrs | ₹65.23m | 0.67% ₹ 2.7b | |
| CFO, MD & Executive Director | 30.3yrs | ₹84.44m | 0.017% ₹ 66.4m | |
| Executive Director | 13.3yrs | ₹69.76m | 0.62% ₹ 2.5b | |
| Additional Independent Director | 2.2yrs | ₹1.25m | no data | |
| Lead Independent Director | 5.8yrs | ₹1.60m | 0.00067% ₹ 2.7m | |
| Independent Director | less than a year | ₹250.00k | no data | |
| Independent Director | less than a year | no data | 0.000080% ₹ 321.0k |
9.5yrs
Average Tenure
69yo
Average Age
Experienced Board: IPCALAB's board of directors are considered experienced (9.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 13:03 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ipca Laboratories Limited is covered by 46 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Aditya Khemka | Ambit Capital |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Sanjeev Chiniwar | Anand Rathi Shares and Stock Brokers Limited |